lilly's glp 1 GLP-1 Direct-To-Consumer Move Changes The 'Game Changer' Game Eli Lilly set to leapfrog
Description
It is administered daily through subcutaneous injection
The standard escalation runs: 2mg (weeks 1 through 4), 4mg (weeks 5 through 8), 8mg (weeks 9 through 12), and 12mg from week 13 onward as the maintenance dose
According to the nonprofit health policy organization KFF, approximately 12 percent of adults in the United States (more than 31 million Americans) currently use a GLP-1 medication
10.1111/bph.12313 116
Reconstituted stability varies between peptides
